Drug recall · February 10, 2016
Clonazepam Tablets recall
Why: Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21
- Lots / codes
Lot # 3063759, Exp.07/16
- Quantity
- 868 unit cartons (86,800 tablets)
- Company
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Distribution
- Nationwide
- Initiated
- January 28, 2016 · Voluntary: Firm initiated
- Classified
- February 2, 2016
- Reported
- February 10, 2016
- Ended
- December 21, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.